{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1362825895150522752.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1200/jco.2017.75.7385"}},{"identifier":{"@type":"URI","@value":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2017.75.7385"}}],"dc:title":[{"@value":"Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update"}],"description":[{"type":"abstract","notation":[{"@value":"<jats:sec><jats:title>Purpose</jats:title><jats:p>To update the guideline recommendations on the use of larynx-preservation strategies in the treatment of laryngeal cancer.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>An Expert Panel updated the systematic review of the literature for the period from January 2005 to May 2017.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>The panel confirmed that the use of a larynx-preservation approach for appropriately selected patients does not compromise survival. No larynx-preservation approach offered a survival advantage compared with total laryngectomy and adjuvant therapy as indicated. Changes were supported for the use of endoscopic surgical resection in patients with limited disease (T1, T2) and for initial total laryngectomy in patients with T4a disease or with severe pretreatment laryngeal dysfunction. New recommendations for positron emission tomography imaging for the evaluation of regional nodes after treatment and best measures for evaluating voice and swallowing function were added.</jats:p></jats:sec><jats:sec><jats:title>Recommendations</jats:title><jats:p>Patients with T1, T2 laryngeal cancer should be treated initially with intent to preserve the larynx by using endoscopic resection or radiation therapy, with either leading to similar outcomes. For patients with locally advanced (T3, T4) disease, organ-preservation surgery, combined chemotherapy and radiation, or radiation alone offer the potential for larynx preservation without compromising overall survival. For selected patients with extensive T3 or large T4a lesions and/or poor pretreatment laryngeal function, better survival rates and quality of life may be achieved with total laryngectomy. Patients with clinically involved regional cervical nodes (N+) who have a complete clinical and radiologic imaging response after chemoradiation do not require elective neck dissection. All patients should undergo a pretreatment baseline assessment of voice and swallowing function and receive counseling with regard to the potential impact of treatment options on voice, swallowing, and quality of life. Additional information is available at www.asco.org/head-neck-cancer-guidelines and www.asco.org/guidelineswiki .</jats:p></jats:sec>"}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1382825895150522762","@type":"Researcher","foaf:name":[{"@value":"Arlene A. Forastiere"}],"jpcoar:affiliationName":[{"@value":"Arlene A. Forastiere, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Nofisat Ismaila, American Society of Clinical Oncology, Alexandria, VA; Jan S. Lewin and Randy Weber, The University of Texas MD Anderson Cancer Center, Houston, TX; Cherie Ann Nathan, LSU Health, Shreveport, LA; David J. Adelstein, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; Avraham Eisbruch and Gregory T. Wolf, University of Michigan, Ann Arbor, MI; Gail Fass, Support for People With Oral..."}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895150522758","@type":"Researcher","foaf:name":[{"@value":"Nofisat Ismaila"}],"jpcoar:affiliationName":[{"@value":"Arlene A. Forastiere, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Nofisat Ismaila, American Society of Clinical Oncology, Alexandria, VA; Jan S. Lewin and Randy Weber, The University of Texas MD Anderson Cancer Center, Houston, TX; Cherie Ann Nathan, LSU Health, Shreveport, LA; David J. Adelstein, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; Avraham Eisbruch and Gregory T. Wolf, University of Michigan, Ann Arbor, MI; Gail Fass, Support for People With Oral..."}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895150522766","@type":"Researcher","foaf:name":[{"@value":"Jan S. Lewin"}],"jpcoar:affiliationName":[{"@value":"Arlene A. Forastiere, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Nofisat Ismaila, American Society of Clinical Oncology, Alexandria, VA; Jan S. Lewin and Randy Weber, The University of Texas MD Anderson Cancer Center, Houston, TX; Cherie Ann Nathan, LSU Health, Shreveport, LA; David J. Adelstein, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; Avraham Eisbruch and Gregory T. Wolf, University of Michigan, Ann Arbor, MI; Gail Fass, Support for People With Oral..."}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895150522759","@type":"Researcher","foaf:name":[{"@value":"Cherie Ann Nathan"}],"jpcoar:affiliationName":[{"@value":"Arlene A. Forastiere, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Nofisat Ismaila, American Society of Clinical Oncology, Alexandria, VA; Jan S. Lewin and Randy Weber, The University of Texas MD Anderson Cancer Center, Houston, TX; Cherie Ann Nathan, LSU Health, Shreveport, LA; David J. Adelstein, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; Avraham Eisbruch and Gregory T. Wolf, University of Michigan, Ann Arbor, MI; Gail Fass, Support for People With Oral..."}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895150522767","@type":"Researcher","foaf:name":[{"@value":"David J. Adelstein"}],"jpcoar:affiliationName":[{"@value":"Arlene A. Forastiere, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Nofisat Ismaila, American Society of Clinical Oncology, Alexandria, VA; Jan S. Lewin and Randy Weber, The University of Texas MD Anderson Cancer Center, Houston, TX; Cherie Ann Nathan, LSU Health, Shreveport, LA; David J. Adelstein, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; Avraham Eisbruch and Gregory T. Wolf, University of Michigan, Ann Arbor, MI; Gail Fass, Support for People With Oral..."}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895150522760","@type":"Researcher","foaf:name":[{"@value":"Avraham Eisbruch"}],"jpcoar:affiliationName":[{"@value":"Arlene A. Forastiere, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Nofisat Ismaila, American Society of Clinical Oncology, Alexandria, VA; Jan S. Lewin and Randy Weber, The University of Texas MD Anderson Cancer Center, Houston, TX; Cherie Ann Nathan, LSU Health, Shreveport, LA; David J. Adelstein, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; Avraham Eisbruch and Gregory T. Wolf, University of Michigan, Ann Arbor, MI; Gail Fass, Support for People With Oral..."}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895150522761","@type":"Researcher","foaf:name":[{"@value":"Gail Fass"}],"jpcoar:affiliationName":[{"@value":"Arlene A. Forastiere, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Nofisat Ismaila, American Society of Clinical Oncology, Alexandria, VA; Jan S. Lewin and Randy Weber, The University of Texas MD Anderson Cancer Center, Houston, TX; Cherie Ann Nathan, LSU Health, Shreveport, LA; David J. Adelstein, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; Avraham Eisbruch and Gregory T. Wolf, University of Michigan, Ann Arbor, MI; Gail Fass, Support for People With Oral..."}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895150522765","@type":"Researcher","foaf:name":[{"@value":"Susan G. Fisher"}],"jpcoar:affiliationName":[{"@value":"Arlene A. Forastiere, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Nofisat Ismaila, American Society of Clinical Oncology, Alexandria, VA; Jan S. Lewin and Randy Weber, The University of Texas MD Anderson Cancer Center, Houston, TX; Cherie Ann Nathan, LSU Health, Shreveport, LA; David J. Adelstein, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; Avraham Eisbruch and Gregory T. Wolf, University of Michigan, Ann Arbor, MI; Gail Fass, Support for People With Oral..."}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895150522757","@type":"Researcher","foaf:name":[{"@value":"Scott A. Laurie"}],"jpcoar:affiliationName":[{"@value":"Arlene A. Forastiere, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Nofisat Ismaila, American Society of Clinical Oncology, Alexandria, VA; Jan S. Lewin and Randy Weber, The University of Texas MD Anderson Cancer Center, Houston, TX; Cherie Ann Nathan, LSU Health, Shreveport, LA; David J. Adelstein, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; Avraham Eisbruch and Gregory T. Wolf, University of Michigan, Ann Arbor, MI; Gail Fass, Support for People With Oral..."}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895150522755","@type":"Researcher","foaf:name":[{"@value":"Quynh-Thu Le"}],"jpcoar:affiliationName":[{"@value":"Arlene A. Forastiere, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Nofisat Ismaila, American Society of Clinical Oncology, Alexandria, VA; Jan S. Lewin and Randy Weber, The University of Texas MD Anderson Cancer Center, Houston, TX; Cherie Ann Nathan, LSU Health, Shreveport, LA; David J. Adelstein, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; Avraham Eisbruch and Gregory T. Wolf, University of Michigan, Ann Arbor, MI; Gail Fass, Support for People With Oral..."}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895150522754","@type":"Researcher","foaf:name":[{"@value":"Bernard O’Malley"}],"jpcoar:affiliationName":[{"@value":"Arlene A. Forastiere, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Nofisat Ismaila, American Society of Clinical Oncology, Alexandria, VA; Jan S. Lewin and Randy Weber, The University of Texas MD Anderson Cancer Center, Houston, TX; Cherie Ann Nathan, LSU Health, Shreveport, LA; David J. Adelstein, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; Avraham Eisbruch and Gregory T. Wolf, University of Michigan, Ann Arbor, MI; Gail Fass, Support for People With Oral..."}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895150522764","@type":"Researcher","foaf:name":[{"@value":"William M. Mendenhall"}],"jpcoar:affiliationName":[{"@value":"Arlene A. Forastiere, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Nofisat Ismaila, American Society of Clinical Oncology, Alexandria, VA; Jan S. Lewin and Randy Weber, The University of Texas MD Anderson Cancer Center, Houston, TX; Cherie Ann Nathan, LSU Health, Shreveport, LA; David J. Adelstein, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; Avraham Eisbruch and Gregory T. Wolf, University of Michigan, Ann Arbor, MI; Gail Fass, Support for People With Oral..."}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895150522752","@type":"Researcher","foaf:name":[{"@value":"Snehal Patel"}],"jpcoar:affiliationName":[{"@value":"Arlene A. Forastiere, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Nofisat Ismaila, American Society of Clinical Oncology, Alexandria, VA; Jan S. Lewin and Randy Weber, The University of Texas MD Anderson Cancer Center, Houston, TX; Cherie Ann Nathan, LSU Health, Shreveport, LA; David J. Adelstein, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; Avraham Eisbruch and Gregory T. Wolf, University of Michigan, Ann Arbor, MI; Gail Fass, Support for People With Oral..."}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895150522880","@type":"Researcher","foaf:name":[{"@value":"David G. Pfister"}],"jpcoar:affiliationName":[{"@value":"Arlene A. Forastiere, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Nofisat Ismaila, American Society of Clinical Oncology, Alexandria, VA; Jan S. Lewin and Randy Weber, The University of Texas MD Anderson Cancer Center, Houston, TX; Cherie Ann Nathan, LSU Health, Shreveport, LA; David J. Adelstein, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; Avraham Eisbruch and Gregory T. Wolf, University of Michigan, Ann Arbor, MI; Gail Fass, Support for People With Oral..."}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895150522753","@type":"Researcher","foaf:name":[{"@value":"Anthony F. Provenzano"}],"jpcoar:affiliationName":[{"@value":"Arlene A. Forastiere, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Nofisat Ismaila, American Society of Clinical Oncology, Alexandria, VA; Jan S. Lewin and Randy Weber, The University of Texas MD Anderson Cancer Center, Houston, TX; Cherie Ann Nathan, LSU Health, Shreveport, LA; David J. Adelstein, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; Avraham Eisbruch and Gregory T. Wolf, University of Michigan, Ann Arbor, MI; Gail Fass, Support for People With Oral..."}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895150522763","@type":"Researcher","foaf:name":[{"@value":"Randy Weber"}],"jpcoar:affiliationName":[{"@value":"Arlene A. Forastiere, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Nofisat Ismaila, American Society of Clinical Oncology, Alexandria, VA; Jan S. Lewin and Randy Weber, The University of Texas MD Anderson Cancer Center, Houston, TX; Cherie Ann Nathan, LSU Health, Shreveport, LA; David J. Adelstein, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; Avraham Eisbruch and Gregory T. Wolf, University of Michigan, Ann Arbor, MI; Gail Fass, Support for People With Oral..."}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895150522756","@type":"Researcher","foaf:name":[{"@value":"Gregory S. Weinstein"}],"jpcoar:affiliationName":[{"@value":"Arlene A. Forastiere, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Nofisat Ismaila, American Society of Clinical Oncology, Alexandria, VA; Jan S. Lewin and Randy Weber, The University of Texas MD Anderson Cancer Center, Houston, TX; Cherie Ann Nathan, LSU Health, Shreveport, LA; David J. Adelstein, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; Avraham Eisbruch and Gregory T. Wolf, University of Michigan, Ann Arbor, MI; Gail Fass, Support for People With Oral..."}]},{"@id":"https://cir.nii.ac.jp/crid/1382825895150522768","@type":"Researcher","foaf:name":[{"@value":"Gregory T. Wolf"}],"jpcoar:affiliationName":[{"@value":"Arlene A. Forastiere, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Nofisat Ismaila, American Society of Clinical Oncology, Alexandria, VA; Jan S. Lewin and Randy Weber, The University of Texas MD Anderson Cancer Center, Houston, TX; Cherie Ann Nathan, LSU Health, Shreveport, LA; David J. Adelstein, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; Avraham Eisbruch and Gregory T. Wolf, University of Michigan, Ann Arbor, MI; Gail Fass, Support for People With Oral..."}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"0732183X"},{"@type":"EISSN","@value":"15277755"}],"prism:publicationName":[{"@value":"Journal of Clinical Oncology"}],"dc:publisher":[{"@value":"American Society of Clinical Oncology (ASCO)"}],"prism:publicationDate":"2018-04-10","prism:volume":"36","prism:number":"11","prism:startingPage":"1143","prism:endingPage":"1169"},"reviewed":"false","url":[{"@id":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2017.75.7385"}],"createdAt":"2017-11-27","modifiedAt":"2024-06-29","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360013168880697728","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Total lesion glycolysis as a predictor of clinical T3–4a laryngeal cancer with laryngectomy or nonlaryngectomy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360016870446974976","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Deep learning approach of diffusion-weighted imaging as an outcome predictor in laryngeal and hypopharyngeal cancer patients with radiotherapy-related curative treatment: a preliminary study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021389810663680","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The process of reacquiring new vocalization in total laryngectomy patients with head and neck cancer: A qualitative study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360306904386135936","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Dosimetric impact of VMAT delivery angles for early glottic cancer treatment"}]},{"@id":"https://cir.nii.ac.jp/crid/1390010292760547200","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Transoral Laser Microsurgery for Early Glottic Carcinoma in Japanese Patients Over 75 Years Old"},{"@language":"ja","@value":"高齢者喉頭癌の治療戦略 -経口的手術の立場から-"}]},{"@id":"https://cir.nii.ac.jp/crid/1390305179448035200","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Local Control of Laryngeal Cancer by Radiotherapy and Boron Neutron Capture Therapy (BNCT) for Cases of Local Recurrence"},{"@language":"ja","@value":"喉頭癌の照射後局所再発例に対するホウ素中性子補足療法（BNCT）"},{"@language":"ja-Kana","@value":"コウトウ ガン ノ ショウシャ ゴ キョクショ サイハツレイ ニ タイスル ホウソ チュウセイシ ホソク リョウホウ(BNCT)"}]},{"@id":"https://cir.nii.ac.jp/crid/1390565134815263232","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"A retrospective study on T2N0 laryngeal cancer"},{"@language":"ja","@value":"当科における喉頭癌T2N0症例の検討"}]},{"@id":"https://cir.nii.ac.jp/crid/1390566775135182336","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Transoral Surgery for Laryngeal Cancer"},{"@language":"ja","@value":"喉頭癌に対する経口的切除術"}]},{"@id":"https://cir.nii.ac.jp/crid/1390851497213788288","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Variation of treatment decision-making for laryngeal cancer in Japan a retrospective observational study using a claim- and electronic medical record-based database"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1200/jco.2017.75.7385"},{"@type":"CROSSREF","@value":"10.1097/md.0000000000027427_references_DOI_Uj6HpNfAAoswg4KAZg1xrxZHisW"},{"@type":"CROSSREF","@value":"10.1016/j.apjon.2023.100362_references_DOI_Uj6HpNfAAoswg4KAZg1xrxZHisW"},{"@type":"CROSSREF","@value":"10.5426/larynx.31.75_references_DOI_Uj6HpNfAAoswg4KAZg1xrxZHisW"},{"@type":"CROSSREF","@value":"10.1007/s00330-022-08630-9_references_DOI_Uj6HpNfAAoswg4KAZg1xrxZHisW"},{"@type":"CROSSREF","@value":"10.2468/jbes.76.189_references_DOI_Uj6HpNfAAoswg4KAZg1xrxZHisW"},{"@type":"CROSSREF","@value":"10.1016/j.meddos.2024.04.001_references_DOI_Uj6HpNfAAoswg4KAZg1xrxZHisW"},{"@type":"CROSSREF","@value":"10.5106/jjshns.29.135_references_DOI_Uj6HpNfAAoswg4KAZg1xrxZHisW"},{"@type":"CROSSREF","@value":"10.37737/ace.3.3_88_references_DOI_Uj6HpNfAAoswg4KAZg1xrxZHisW"},{"@type":"CROSSREF","@value":"10.5426/larynx.33.114_references_DOI_Uj6HpNfAAoswg4KAZg1xrxZHisW"}]}